Moderna's quadrivalent flu vaccine mRNA-1010 boosted titres against all four strains 29 days after vaccination in young and older adults.
List view / Grid view
A newly designed 3D-printed microneedle patch demonstrated immune responses 50 times greater than typical subcutaneous injection in animals.
A new report has highlighted that the early successes of Avigan (favipiravir) and DAS181 do not guarantee their efficacy against COVID-19.
Rompe Pecho EX, Rompe Pecho CF and Rompe Pecho MAXliquid are being recalled due to microbial contamination.
New vaccine patch has showed no negative side effects and could lead to a replacement of needle-based vaccination methods.
NIR spectroscopy could be used to improve the manufacture of flu vaccines by showing optimal times of harvesting cells and detecting problems quicker...